Article
Health, biotech & medtech

Hungarian cancer research innovation takes top prize in London – Dr. István Peták’s development

HU · Magyar rákkutatási innováció a világ legjobbja Londonban! – Dr. Peták István fejlesztése

Dr. István Peták's development won the top prize in the healthcare category of the Blue Earth Summit BE100 innovation competition in London. Genomate Health's technology, developed by Hungarian researchers, mathematically analyzes the genetic variations of a tumor, drugs and scientific evidence to rank potential targeted therapies. The article discusses the company's previous international recognitions, its merger with Oncompass Medicine, and the fact that the solution is currently available in private care in Hungary.

Hungarian cancer research innovation takes top prize in London – Dr. István Peták’s development

Executive summary (AI)

  • Dr. István Peták's development, Genomate Health's technology, won the healthcare grand prize of the Blue Earth Summit BE100 competition; 1,414 applications were submitted to the competition, with 100 reaching the finals.
  • The technology mathematically analyzes the relationships between tumor gene mutations, drugs, and scientific evidence, and then ranks potential targeted therapies.
  • According to the article, the innovation was recognized in the spring of 2026 by the American C3 Davos Silicon Valley Healthcare Summit and the AACR; Genomate Health merged with Budapest-based Oncompass Medicine in early 2026, and the solutions are currently available in private care in Hungary.
KockázatiTőke.comRead original ↗